Schlicht H J, Schaller H
Zentrum für Molekulare Biologie, Universität Heidelberg, Federal Republic of Germany.
J Virol. 1989 Dec;63(12):5399-404. doi: 10.1128/JVI.63.12.5399-5404.1989.
Human hepatitis B virus (HBV) causes acute and chronic liver disease, which can result in tumor formation. An as yet unexplained phenomenon is that virus elimination usually correlates with the development of antibodies directed against the HBeAg, a secretory HBV core gene product which can be detected in the serum of infected patients. Expression of HBeAg in a human hepatoma cell line by using recombinant vaccinia viruses revealed that the HBeAg is not only secreted from HBeAg-producing cells but also incorporated into the outer cell membrane. No membrane-expressed core gene product could be detected when the cytoplasmic core protein (HBcAg) was expressed. Immune sera from patients who developed anti-HBe antibodies efficiently recognized the membrane-bound HBeAg, suggesting that surface-expressed HBeAg can serve as a target for an antibody-mediated elimination of HBV-infected cells.
人类乙型肝炎病毒(HBV)可引发急慢性肝病,进而可能导致肿瘤形成。一个尚未得到解释的现象是,病毒清除通常与针对HBeAg(一种分泌性HBV核心基因产物,可在感染患者血清中检测到)的抗体的产生相关。通过使用重组痘苗病毒在人肝癌细胞系中表达HBeAg发现,HBeAg不仅从产生HBeAg的细胞中分泌出来,还整合到细胞膜外。当表达细胞质核心蛋白(HBcAg)时,未检测到膜表达的核心基因产物。产生抗HBe抗体的患者的免疫血清能够有效识别膜结合的HBeAg,这表明表面表达的HBeAg可作为抗体介导清除HBV感染细胞的靶点。